EPS for Brookline Bancorp, Inc. (BRKL) Expected At $0.20; LeMaitre Vascular (LMAT) Had 8 Analysts Last Week

July 3, 2017 - By Nellie Frank

Analysts expect Brookline Bancorp, Inc. (NASDAQ:BRKL) to report $0.20 EPS on July, 19.They anticipate $0.02 EPS change or 11.11% from last quarter’s $0.18 EPS. BRKL’s profit would be $15.21 million giving it 18.25 P/E if the $0.20 EPS is correct. After having $0.19 EPS previously, Brookline Bancorp, Inc.’s analysts see 5.26% EPS growth. The stock decreased 0.68% or $0.1 on June 30, reaching $14.6. About shares traded. Brookline Bancorp, Inc. (NASDAQ:BRKL) has risen 26.02% since July 3, 2016 and is uptrending. It has outperformed by 9.32% the S&P500.

Among 10 analysts covering LeMaitre Vascular (NASDAQ:LMAT), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. LeMaitre Vascular had 24 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, December 7 by Dougherty & Company. The stock of LeMaitre Vascular Inc (NASDAQ:LMAT) earned “Mkt Perform” rating by Barrington Research on Wednesday, February 22. Barrington Research upgraded it to “Outperform” rating and $14 target in Wednesday, October 28 report. Roth Capital maintained LeMaitre Vascular Inc (NASDAQ:LMAT) on Tuesday, May 3 with “Buy” rating. The firm earned “Buy” rating on Monday, December 7 by Roth Capital. The stock has “Neutral” rating by Sidoti on Thursday, September 22. TH Capital maintained the shares of LMAT in report on Monday, December 7 with “Buy” rating. Cowen & Co maintained LeMaitre Vascular Inc (NASDAQ:LMAT) rating on Thursday, April 21. Cowen & Co has “Outperform” rating and $93 target. Stifel Nicolaus maintained the stock with “Buy” rating in Friday, December 4 report. The rating was maintained by Benchmark with “Buy” on Wednesday, July 29. See LeMaitre Vascular Inc (NASDAQ:LMAT) latest ratings:

21/03/2017 Broker: First Analysis Rating: Overweight New Target: $29.00 Initiates Coverage On
22/02/2017 Broker: Barrington Research Old Rating: Outperform New Rating: Mkt Perform Downgrade

Investors sentiment increased to 1.1 in 2016 Q4. Its up 0.05, from 1.05 in 2016Q3. It improved, as 10 investors sold Brookline Bancorp, Inc. shares while 58 reduced holdings. 21 funds opened positions while 54 raised stakes. 51.92 million shares or 2.77% more from 50.52 million shares in 2016Q3 were reported. Contravisory, Massachusetts-based fund reported 14,432 shares. State Of Alaska Department Of Revenue owns 0.01% invested in Brookline Bancorp, Inc. (NASDAQ:BRKL) for 7,630 shares. Texas Permanent School Fund holds 51,443 shares. Moreover, Btim has 0% invested in Brookline Bancorp, Inc. (NASDAQ:BRKL) for 10,000 shares. Jacobs Levy Equity Mngmt stated it has 19,280 shares or 0.01% of all its holdings. Nationwide Fund stated it has 200,919 shares. Gsa Capital Prtnrs Llp accumulated 41,370 shares. Loring Wolcott And Coolidge Fiduciary Advsr Llp Ma invested in 0.04% or 112,212 shares. Geode Capital Mgmt Limited Liability Co stated it has 609,604 shares or 0% of all its holdings. Hsbc Hldg Public Limited Com has invested 0% in Brookline Bancorp, Inc. (NASDAQ:BRKL). Crestwood Limited Com holds 12,665 shares. Baldwin Brothers Ma holds 0.08% or 25,990 shares. State Street Corp accumulated 2.09 million shares. 18,302 are owned by Parsons Capital Management Ri. Nordea Invest Management has invested 0.02% in Brookline Bancorp, Inc. (NASDAQ:BRKL).

Since June 5, 2017, it had 0 buys, and 1 insider sale for $69,509 activity. McCurdy Michael W. also sold $69,509 worth of Brookline Bancorp, Inc. (NASDAQ:BRKL) shares.

Brookline Bancorp, Inc. operates as a multi-bank holding firm for Brookline Bank and its subsidiaries; Bank Rhode Island and its subsidiaries; First Ipswich Bank (First Ipswich) and its subsidiaries, and Brookline Securities Corp. The company has market cap of $1.11 billion. As a commercially focused financial institution with 50 full-service banking offices throughout greater Boston, the north shore of Massachusetts and Rhode Island, the Company, through Brookline Bank, BankRI and First Ipswich (individually and collectively the Banks), offered a range of commercial, business and retail banking services, including cash management products, online banking services, consumer and residential loans and investment services throughout central New England, as of December 31, 2016. It has a 19.44 P/E ratio.

Among 4 analysts covering Brookline Bancorp (NASDAQ:BRKL), 0 have Buy rating, 0 Sell and 4 Hold. Therefore 0 are positive. Brookline Bancorp had 6 analyst reports since September 3, 2015 according to SRatingsIntel. The rating was downgraded by Sandler O’Neill to “Hold” on Tuesday, June 7. Compass Point upgraded the shares of BRKL in report on Thursday, October 22 to “Buy” rating. The firm earned “Buy” rating on Thursday, September 3 by Sandler O’Neill. The rating was initiated by Piper Jaffray with “Neutral” on Wednesday, September 16. The stock of Brookline Bancorp, Inc. (NASDAQ:BRKL) has “Hold” rating given on Thursday, June 1 by Keefe Bruyette & Woods. Compass Point downgraded Brookline Bancorp, Inc. (NASDAQ:BRKL) on Friday, November 18 to “Neutral” rating.

Investors sentiment decreased to 1.12 in Q4 2016. Its down 0.44, from 1.56 in 2016Q3. It dived, as 11 investors sold LeMaitre Vascular Inc shares while 39 reduced holdings. 18 funds opened positions while 38 raised stakes. 10.81 million shares or 0.20% more from 10.78 million shares in 2016Q3 were reported. Northwestern Mutual Wealth Management Communication reported 28 shares. Tiaa Cref Investment Limited Liability Co holds 0% or 98,685 shares in its portfolio. Rhumbline Advisers has 0% invested in LeMaitre Vascular Inc (NASDAQ:LMAT). Cornerstone Management accumulated 0.03% or 163,789 shares. Bogle Invest L P De reported 0.18% of its portfolio in LeMaitre Vascular Inc (NASDAQ:LMAT). New York-based Art Limited Liability Co has invested 0.02% in LeMaitre Vascular Inc (NASDAQ:LMAT). Jfs Wealth Ltd Liability holds 1,000 shares. Citigroup holds 0% or 13,592 shares. State Street stated it has 329,877 shares or 0% of all its holdings. Vanguard Gp accumulated 619,883 shares. Campbell And Adviser Lc accumulated 8,046 shares or 0.63% of the stock. Prudential Financial holds 0% in LeMaitre Vascular Inc (NASDAQ:LMAT) or 95,310 shares. Susquehanna Int Gru Llp holds 0% of its portfolio in LeMaitre Vascular Inc (NASDAQ:LMAT) for 22,038 shares. Manufacturers Life The invested 0% of its portfolio in LeMaitre Vascular Inc (NASDAQ:LMAT). Parametric Port Associate Ltd Liability Com holds 0% or 75,603 shares.

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The company has market cap of $590.82 million. The Firm develops, makes and markets medical devices and implants used primarily in the field of vascular surgery. It has a 52.02 P/E ratio. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.

Since February 27, 2017, it had 0 insider purchases, and 9 insider sales for $8.92 million activity. Another trade for 15,780 shares valued at $477,822 was made by Kamke Trent G on Wednesday, May 24. On Monday, May 8 LeMaitre George W sold $1.97M worth of LeMaitre Vascular Inc (NASDAQ:LMAT) or 63,622 shares. Roberts David B also sold $1.20 million worth of LeMaitre Vascular Inc (NASDAQ:LMAT) on Thursday, May 11. 2,346 shares were sold by Wijas Michael T, worth $73,717 on Thursday, June 1.

The stock increased 0.61% or $0.19 on June 30, reaching $31.22. About shares traded. LeMaitre Vascular Inc (NASDAQ:LMAT) has risen 101.07% since July 3, 2016 and is uptrending. It has outperformed by 84.37% the S&P500.